60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
Q1 2024 vs. Q4 2023
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 4 | 8 | +4 |
| Shares | 462.7K | 485.4K | +22.7K (+4.9%) |
| Value | $467.4K | $126.6K | −$340.8K (−72.9%) |
New holders (5)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 100,630 | $26.3K | 0.00% |
| Virtu Financial LLC | 59,516 | $16.0K | 0.00% |
| Two Sigma Securities, LLC | 24,186 | $6.31K | 0.00% |
| Susquehanna International Group, LLP | 13,545 | $3.54K | 0.00% |
| Renaissance Technologies LLC | 12,564 | $3.00K | 0.00% |
Sold out (1)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Walleye Capital LLC | 102,624 | $103.7K |